NSRX today
$2.91-$0.07 (-2.51%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minBearish
5 minConsolidating
Daily trend turns down below $1.98
Key levels
Resistance$3.63
Resistance$3.05
Support$2.75
Support$2.41
Latest news & SEC filings
AnalystMaxim Group starts Nasus Pharma coverage with Buy rating
AnalystMaxim Group starts Nasus Pharma coverage with Buy rating and $7 price target
All NSRX news →About Nasus Pharma
Nasus Pharma is a clinical-stage pharmaceutical company developing intranasal powder medicines, including epinephrine and naloxone products delivered through the nose. Its pipeline programs are at different points in clinical testing and none has received marketing approval yet. The company operates in Israel and depends on outside manufacturers and suppliers for its development work.
Based on the company's 20-F filed Mar 25, 2026.
NYSE · Healthcare
Nasus Pharma Ltd (NSRX)
What Is the Price Target for NSRX?
SEPT Low Target
$15.30
SEPT Mid Target
$18.00
SEPT High Target
$20.70
Analyst Consensus
$18.00
Is NSRX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NSRX.
Start Free Trial →Is NSRX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$18.00
5
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with NSRX?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NSRX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-41.67%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for NSRX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NSRX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:32:38 | $2.90 | 1,000 | $$3K | BUY |
| 17:03:24 | $2.90 | 2,962 | $$9K | SELL |
| 16:59:28 | $2.87 | 3,000 | $$9K | SELL |
| 15:01:06 | $2.96 | 1,200 | $$4K | BUY |
| 15:59:39 | $2.90 | 1,500 | $$4K | SELL |
5 dark pool trades shown · $$28K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Nasus Pharma Ltd (NSRX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NSRX — frequently asked questions
What is NSRX stock price today?
Nasus Pharma Ltd (NSRX) is at $2.91, down 2.51% (-$0.07) at the Nov 11, 2026 close.
Why is NSRX stock moving today?
Latest NSRX news — Oct 31, 2026: Maxim Group starts Nasus Pharma coverage with Buy rating · Oct 30, 2026: Maxim Group starts Nasus Pharma coverage with Buy rating and $7 price target
What is the NSRX price target?
The average analyst price target for NSRX is $18.00, ranging from $18 to $18, based on 1 analysts. Latest: Citizens maintains on Mar 26, 2026.
What do analysts rate NSRX?
Analyst ratings for NSRX: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did NSRX beat earnings?
NSRX last reported on Aug 17, 2026: EPS -$0.54 vs -$0.27 expected — a miss of 100.0%.
Does NSRX pay a dividend?
NSRX does not currently pay a dividend.
What are NSRX support and resistance levels?
Support: $2.75, $2.41, $2.10. Resistance: $3.05, $3.63, $4.10.
What are insiders doing with NSRX?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on NSRX?
Oct 31, 2026: Maxim Group starts Nasus Pharma coverage with Buy rating · Oct 30, 2026: Maxim Group starts Nasus Pharma coverage with Buy rating and $7 price target